Related Experiment Video
Updated: Jul 6, 2026
09:29
Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
Published on: August 21, 2017
Guillain-Barré syndrome
1Department of Neurology, University of Virginia, PO Box800394, Charlottesville, VA 22908, USA. tmb8r@virginia.edu
Seminars in Neurology
|March 21, 2008
Summary
Guillain-Barré syndrome (GBS) is an immune-mediated nerve disorder often triggered by infection. Early diagnosis through clinical assessment, supported by tests, and prompt treatment with immunoglobulin or plasma exchange are vital for recovery.
Area of Science:
- Neurology
- Immunology
- Infectious Disease
Background:
- Guillain-Barré syndrome (GBS) is an acute, immune-mediated polyneuropathy.
- It frequently follows an antecedent infection.
- Accurate diagnosis is critical for effective management.
Purpose of the Study:
- To summarize the key aspects of Guillain-Barré syndrome diagnosis and management.
- To highlight the importance of clinical evaluation and supportive diagnostic tools.
- To emphasize effective treatment options and supportive care.
Main Methods:
- Clinical diagnosis based on history and neurological examination.
- Cerebrospinal fluid (CSF) analysis.
- Electrodiagnostic testing (nerve conduction studies, EMG).
Main Results:
- Diagnosis primarily relies on clinical presentation.
- CSF analysis and electrodiagnostic tests provide supportive evidence.
- Recognition of mimics and variants is essential for accurate diagnosis.
Conclusions:
- Prompt and accurate diagnosis of GBS is crucial.
- Intravenous immunoglobulin and plasma exchange are effective treatments.
- Comprehensive supportive care is vital during and after hospitalization.
More Related Videos
Related Concept Videos
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:22Botulism
Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:15Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
01:17Poliomyelitis
Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...